Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
about
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).The use of fibroblast growth factor 23 testing in patients with kidney disease.Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure.Fibroblast growth factor-23 and cardiovascular events in CKD.The impact of arteriovenous fistulae on the myocardium: the impact of creation and ligation in the transplant era.Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury.Effects of klotho deletion from bone during chronic kidney disease.Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.FGF23 and Left Ventricular Hypertrophy in Children with CKD.Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Phosphate and Cardiovascular Disease beyond Chronic Kidney Disease and Vascular Calcification.
P2860
Q33591588-84FDFDA1-78E8-4482-8C2C-12FA3D5DBA52Q33835743-233784C4-94AD-44E3-8FC6-05D5992C74CAQ37126261-AE89BD9D-5D0C-4E75-B020-119216324C9BQ37524119-00B92450-754D-4340-973A-B5F3826D9166Q38255386-8C4D21EF-759F-4727-AD5D-5934A1025148Q38690776-CD08B2C3-ABA4-4D0B-A953-79D26670966CQ39003429-99E2B8D9-CB06-458D-8AD6-814AB3EBF0E7Q39148454-BF7F9802-DA35-4554-B89B-92AD6DFFDC63Q40279706-C499DCBF-994D-4D18-8790-B18509B10792Q41007543-6E7717AC-F66A-44AC-B47D-2EAAE45C40E4Q45134043-4C228408-E5F9-47C2-BAAB-CF94254518C9Q46192114-CBD3756B-AC43-416B-8031-EDB8D82782DBQ50613899-A87E0BDB-E8D6-456A-A26D-3D9D1188227EQ53342879-BABD7EA5-1097-4EDF-801D-63680752ACA2Q55098165-393C3C55-EDC2-49CF-B8DD-608808A35787
P2860
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@ast
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@en
type
label
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@ast
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@en
prefLabel
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@ast
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@en
P2093
P2860
P1476
Fibroblast growth factor 23, h ...... entricular hypertrophy in CKD.
@en
P2093
Christopher deFilippi
Karen Laliberte
Kelsey Smith
Michael Hise
Myles Wolf
Orlando M Gutiérrez
Robert Christenson
Show-Hong Duh
Stephen Seliger
Tamara Isakova
P2860
P356
10.1053/J.AJKD.2012.06.022
P577
2012-08-09T00:00:00Z